Back
Regeneron Pharmaceuticals Stock Price Chart
Sponsored
REGN
Sponsored
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
800.47
Seasonality Move:
14.2%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 822.36 | Sell |
20-day SMA: | 888.61 | Sell |
50-day SMA: | 1003.71 | Sell |
200-day SMA: | 1008.1 | Sell |
8-day EMA: | 830.33 | Sell |
20-day EMA: | 881.51 | Sell |
50-day EMA: | 965.43 | Sell |
200-day EMA: | 989.48 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -56.85 | Sell |
Relative Strength Index (14 RSI): | 15.94 | Sell |
Chaikin Money Flow: | -529793 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (836.26 - 990.14) | Sell |
Bollinger Bands (100): | (951.78 - 1157.76) | Sell |
Regeneron Pharmaceuticals Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 804.33 while REGN 8-day simple moving average is 822.36, which is a Sell signal.
- The stock price of REGN is 804.33 while Regeneron Pharmaceuticals 20-day SMA is 888.61, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 1,003.71 while REGN share price is 804.33, making it a Sell technically.
- REGN stock price is 804.33 and Regeneron Pharmaceuticals 200-day simple moving average is 1,008.10, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Sell
The current Regeneron Pharmaceuticals [REGN] share price is $804.33. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
88.39B
Price in USD:
804.33
Share Volume:
587.92K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
784.96
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 804.33 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 804.33 while REGN 8-day exponential moving average is 830.33, which is a Sell signal.
- The stock price of REGN is 804.33 while Regeneron Pharmaceuticals 20-day EMA is 881.51, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day exponential moving average is 965.43 while REGN share price is 804.33, making it a Sell technically.
- REGN stock price is 804.33 and Regeneron Pharmaceuticals 200-day simple moving average is 989.48, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $0.51 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is -56.85, suggesting Regeneron Pharmaceuticals is a Sell
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 15.94, which suggest Regeneron Pharmaceuticals is oversold
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (836.26 - 990.14), which suggest Regeneron Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (951.78 - 1157.76), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.